A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women

NCT02210689 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

604

Enrollment

INDUSTRY

Sponsor class

Conditions

BACTERIAL VAGINOSIS
Signs and Symptoms to be Evaluated and Recorded Include
Vaginal Discharge Color, Odor, and Consistency
Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe
Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe

Interventions

DRUG: clindamycin phosphate vaginal cream 2%
OTHER: placebo

Sponsor

Actavis Inc.

Collaborators

[object Object]